Dermalogica FutureCode Booster

Dermalogica has launched the FutureCode Booster, a damage-correcting longevity serum designed to support the skin's natural repair processes at a cellular level rather than addressing surface concerns alone.

The formula targets visible signs of DNA-related damage including deepening lines, coarse texture and visible discolouration, working to support the skin's resilience and extend the look of healthy skin over time. It is clinically proven to lift and firm after one week, based on an eight-week clinical study with 33 participants using the product twice daily.

The formula is built around four key complexes. The Longevity Renew Complex, combining teprenone, niacinamide and sunflower sprout extract, supports NAD+ levels and the skin's natural repair processes to improve firmness and even tone. An omni-antioxidant blend of acetyl zingerone, rosehip oil and rosemary neutralises multiple types of free radicals to help reverse daily DNA-related damage. A skin-shielding blend of tara fruit extract, red algae and soy protein delivers an immediate firming effect and defends against environmental aggressors. Biomimetic phospholipids strengthen the skin barrier and enhance absorption of the active ingredients, while saccharide isomerate and multiple molecular weights of hyaluronic acid provide deep, lasting hydration.

The booster is designed to be applied morning and night on clean skin, either alone or mixed into a serum or moisturiser to increase the performance of existing products. It can be used up to four times daily.

Dermalogica was founded by Jane Wurwand in 1986, following the establishment of the International Dermal Institute in 1983, which she created after identifying a gap in professional skincare training. The brand launched with clean formulas and a commitment to skin health over beauty, at a time when that approach ran counter to industry norms. Today Dermalogica trains 100,000 skin therapists per year globally.